Search Genes

GET /api/v1/genes/?format=api&page=85
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 35532,
    "next": "https://panelapp-aus.org/api/v1/genes/?format=api&page=86",
    "previous": "https://panelapp-aus.org/api/v1/genes/?format=api&page=84",
    "results": [
        {
            "gene_data": {
                "alias": [
                    "MGCR1-PEN",
                    "MGCR1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7180",
                "gene_name": "MN1 proto-oncogene, transcriptional regulator",
                "omim_gene": [
                    "156100"
                ],
                "alias_name": [
                    "probable tumor suppressor protein MN1"
                ],
                "gene_symbol": "MN1",
                "hgnc_symbol": "MN1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:28144265-28197486",
                            "ensembl_id": "ENSG00000169184"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:27748277-27801498",
                            "ensembl_id": "ENSG00000169184"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-06-08"
            },
            "entity_type": "gene",
            "entity_name": "MN1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "31834374",
                "31839203"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "CEBALID syndrome, MIM#618774",
                "Intellectual disability",
                "dysmophic features",
                "rhombencephalosynapsis"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HB9",
                    "HOXHB9",
                    "SCRA1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4979",
                "gene_name": "motor neuron and pancreas homeobox 1",
                "omim_gene": [
                    "142994"
                ],
                "alias_name": null,
                "gene_symbol": "MNX1",
                "hgnc_symbol": "MNX1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:156786745-156803345",
                            "ensembl_id": "ENSG00000130675"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:156994051-157010651",
                            "ensembl_id": "ENSG00000130675"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-09"
            },
            "entity_type": "gene",
            "entity_name": "MNX1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32571425",
                "33836786",
                "11528505"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Currarino syndrome, MIM# 176450",
                "Permanent neonatal diabetes mellitus, MONDO:0100164, MNX1-related"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HMCS",
                    "FLJ20733",
                    "MOS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18234",
                "gene_name": "molybdenum cofactor sulfurase",
                "omim_gene": [
                    "613274"
                ],
                "alias_name": null,
                "gene_symbol": "MOCOS",
                "hgnc_symbol": "MOCOS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:33767482-33852120",
                            "ensembl_id": "ENSG00000075643"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:36187519-36272157",
                            "ensembl_id": "ENSG00000075643"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-12-18"
            },
            "entity_type": "gene",
            "entity_name": "MOCOS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11302742",
                "17368066",
                "14624414",
                "25967871",
                "34356852",
                "32073534",
                "30758870",
                "27919260"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Xanthinuria type II, MIM#603592"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MOCOD"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7190",
                "gene_name": "molybdenum cofactor synthesis 1",
                "omim_gene": [
                    "603707"
                ],
                "alias_name": null,
                "gene_symbol": "MOCS1",
                "hgnc_symbol": "MOCS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:39867354-39902290",
                            "ensembl_id": "ENSG00000124615"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:39899578-39934551",
                            "ensembl_id": "ENSG00000124615"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-23"
            },
            "entity_type": "gene",
            "entity_name": "MOCS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21031595",
                "9921896",
                "12754701",
                "27604308",
                "9731530"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Molybdenum cofactor deficiency A, MIM# 252150"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "treatable"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGI-97",
                    "FLJ10917",
                    "SDS",
                    "SWDS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19440",
                "gene_name": "SBDS, ribosome maturation factor",
                "omim_gene": [
                    "607444"
                ],
                "alias_name": null,
                "gene_symbol": "SBDS",
                "hgnc_symbol": "SBDS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:66452664-66460588",
                            "ensembl_id": "ENSG00000126524"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:66987677-66995601",
                            "ensembl_id": "ENSG00000126524"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-07-02"
            },
            "entity_type": "gene",
            "entity_name": "SBDS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Shwachman-Diamond syndrome, MIM# 260400"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1034",
                    "FLJ21474"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21637",
                "gene_name": "SATB homeobox 2",
                "omim_gene": [
                    "608148"
                ],
                "alias_name": null,
                "gene_symbol": "SATB2",
                "hgnc_symbol": "SATB2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:200134223-200335989",
                            "ensembl_id": "ENSG00000119042"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:199269500-199471266",
                            "ensembl_id": "ENSG00000119042"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-07-08"
            },
            "entity_type": "gene",
            "entity_name": "SATB2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29023086",
                "28151491",
                "32446642"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Glass syndrome, MIM# 612313",
                "MONDO:0100147"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SSAT"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10540",
                "gene_name": "spermidine/spermine N1-acetyltransferase 1",
                "omim_gene": [
                    "313020"
                ],
                "alias_name": [
                    "diamine N-acetyltransferase 1"
                ],
                "gene_symbol": "SAT1",
                "hgnc_symbol": "SAT1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:23801290-23804343",
                            "ensembl_id": "ENSG00000130066"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:23783173-23786226",
                            "ensembl_id": "ENSG00000130066"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-08-24"
            },
            "entity_type": "gene",
            "entity_name": "SAT1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12215835",
                "20672378",
                "9228047",
                "35977808"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Systemic lupus erythematosus, MONDO:0007915, SAT1-related",
                "Keratosis follicularis spinulosa decalvans"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MOCO1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7193",
                "gene_name": "molybdenum cofactor synthesis 2",
                "omim_gene": [
                    "603708"
                ],
                "alias_name": null,
                "gene_symbol": "MOCS2",
                "hgnc_symbol": "MOCS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:52391509-52405893",
                            "ensembl_id": "ENSG00000164172"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:53095679-53110063",
                            "ensembl_id": "ENSG00000164172"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-23"
            },
            "entity_type": "gene",
            "entity_name": "MOCS2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27604308",
                "10053004"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Molybdenum cofactor deficiency B MIM#252160",
                "Disorders of molybdenum cofactor metabolism"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZp761A078",
                    "SAS-6",
                    "FLJ22097",
                    "SAS6"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25403",
                "gene_name": "SAS-6 centriolar assembly protein",
                "omim_gene": [
                    "609321"
                ],
                "alias_name": null,
                "gene_symbol": "SASS6",
                "hgnc_symbol": "SASS6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:100549119-100598511",
                            "ensembl_id": "ENSG00000156876"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:100083563-100132955",
                            "ensembl_id": "ENSG00000156876"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-10-13"
            },
            "entity_type": "gene",
            "entity_name": "SASS6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24951542",
                "30639237",
                "38501757",
                "36739862"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Microcephaly 14, primary, autosomal recessive, MIM# 616402"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0790",
                    "dJ323M4.1",
                    "SH3D6A"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19182",
                "gene_name": "SAM and SH3 domain containing 1",
                "omim_gene": [
                    "607955"
                ],
                "alias_name": null,
                "gene_symbol": "SASH1",
                "hgnc_symbol": "SASH1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:148593440-148873186",
                            "ensembl_id": "ENSG00000111961"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:148272304-148552050",
                            "ensembl_id": "ENSG00000111961"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-11-27"
            },
            "entity_type": "gene",
            "entity_name": "SASH1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23333244",
                "27885802",
                "32981204"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Dyschromatosis universalis hereditaria 1, MIM #127500",
                "familial generalized lentiginosis MONDO:007891"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ20450",
                    "mtSerRS",
                    "SerRSmt",
                    "SARS",
                    "SERS",
                    "SYS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17697",
                "gene_name": "seryl-tRNA synthetase 2, mitochondrial",
                "omim_gene": [
                    "612804"
                ],
                "alias_name": [
                    "serine tRNA ligase 2, mitochondrial"
                ],
                "gene_symbol": "SARS2",
                "hgnc_symbol": "SARS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:39405906-39440495",
                            "ensembl_id": "ENSG00000104835"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:38915266-38930896",
                            "ensembl_id": "ENSG00000104835"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-10-09"
            },
            "entity_type": "gene",
            "entity_name": "SARS2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24034276",
                "21255763",
                "33751860"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, MIM#613845"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SDH"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10536",
                "gene_name": "sarcosine dehydrogenase",
                "omim_gene": [
                    "604455"
                ],
                "alias_name": null,
                "gene_symbol": "SARDH",
                "hgnc_symbol": "SARDH",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:136528682-136605077",
                            "ensembl_id": "ENSG00000123453"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:133663560-133739955",
                            "ensembl_id": "ENSG00000123453"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-03-02"
            },
            "entity_type": "gene",
            "entity_name": "SARDH",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22825317",
                "27604308"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review Amber",
                "Literature",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Sarcosinemia MIM#268900",
                "Disorders of serine, glycine or glycerate metabolism"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10535",
                "gene_name": "secretion associated Ras related GTPase 1B",
                "omim_gene": [
                    "607690"
                ],
                "alias_name": null,
                "gene_symbol": "SAR1B",
                "hgnc_symbol": "SAR1B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:133936834-133984961",
                            "ensembl_id": "ENSG00000152700"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:134601144-134649271",
                            "ensembl_id": "ENSG00000152700"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-10-21"
            },
            "entity_type": "gene",
            "entity_name": "SAR1B",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12692552"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Chylomicron retention disease, MIM# 246700"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SBBI88",
                    "Mg11",
                    "HDDC1",
                    "MOP-5",
                    "AGS5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15925",
                "gene_name": "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1",
                "omim_gene": [
                    "606754"
                ],
                "alias_name": [
                    "HD domain containing 1",
                    "monocyte protein 5",
                    "Aicardi-Goutieres syndrome 5"
                ],
                "gene_symbol": "SAMHD1",
                "hgnc_symbol": "SAMHD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:35518632-35580246",
                            "ensembl_id": "ENSG00000101347"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:36890229-36951843",
                            "ensembl_id": "ENSG00000101347"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-07-31"
            },
            "entity_type": "gene",
            "entity_name": "SAMHD1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19525956",
                "21102625",
                "33307271",
                "20301648"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Aicardi-Goutieres syndrome 5, MIM# 612952"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA2005",
                    "FLJ39885"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1349",
                "gene_name": "sterile alpha motif domain containing 9 like",
                "omim_gene": [
                    "611170"
                ],
                "alias_name": null,
                "gene_symbol": "SAMD9L",
                "hgnc_symbol": "SAMD9L",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:92759368-92777682",
                            "ensembl_id": "ENSG00000177409"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:93130055-93148369",
                            "ensembl_id": "ENSG00000177409"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-04-26"
            },
            "entity_type": "gene",
            "entity_name": "SAMD9L",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "27259050",
                "30923096",
                "30322869",
                "33710394"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ataxia-pancytopenia syndrome, MIM# 159550",
                "Intellectual disability"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "UBA4",
                    "dJ914P20.3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15765",
                "gene_name": "molybdenum cofactor synthesis 3",
                "omim_gene": [
                    "609277"
                ],
                "alias_name": [
                    "ubiquitin-like modifier activating enzyme 4",
                    "UBA4, ubiquitin-activating enzyme E1 homolog (yeast)"
                ],
                "gene_symbol": "MOCS3",
                "hgnc_symbol": "MOCS3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:49575363-49577820",
                            "ensembl_id": "ENSG00000124217"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:50958826-50963931",
                            "ensembl_id": "ENSG00000124217"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-09-17"
            },
            "entity_type": "gene",
            "entity_name": "MOCS3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "33897766",
                "28544736"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Molybdenum cofactor deficiency, type B2, MIM# 621373"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BTN6",
                    "BTNL11"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7197",
                "gene_name": "myelin oligodendrocyte glycoprotein",
                "omim_gene": [
                    "159465"
                ],
                "alias_name": null,
                "gene_symbol": "MOG",
                "hgnc_symbol": "MOG",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:29624758-29640149",
                            "ensembl_id": "ENSG00000204655"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:29656981-29672372",
                            "ensembl_id": "ENSG00000204655"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-03-30"
            },
            "entity_type": "gene",
            "entity_name": "MOG",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21907016"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Narcolepsy 7 , MIM# 614250"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GCS1",
                    "CWH41",
                    "DER7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:24862",
                "gene_name": "mannosyl-oligosaccharide glucosidase",
                "omim_gene": [
                    "601336"
                ],
                "alias_name": [
                    "glucosidase I",
                    "processing A-glucosidase I"
                ],
                "gene_symbol": "MOGS",
                "hgnc_symbol": "MOGS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:74688184-74692537",
                            "ensembl_id": "ENSG00000115275"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:74461057-74465410",
                            "ensembl_id": "ENSG00000115275"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-03-24"
            },
            "entity_type": "gene",
            "entity_name": "MOGS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31925597",
                "30587846",
                "33058492"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Congenital disorder of glycosylation, type IIb 606056"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ZCW3",
                    "KIAA0852",
                    "AC004542.C22.1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23573",
                "gene_name": "MORC family CW-type zinc finger 2",
                "omim_gene": [
                    "616661"
                ],
                "alias_name": null,
                "gene_symbol": "MORC2",
                "hgnc_symbol": "MORC2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:31321117-31364284",
                            "ensembl_id": "ENSG00000133422"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:30925130-30968298",
                            "ensembl_id": "ENSG00000133422"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-06-15"
            },
            "entity_type": "gene",
            "entity_name": "MORC2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32693025",
                "26497905",
                "26659848"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Charcot-Marie-Tooth disease, axonal, type 2Z, MIM# 616688",
                "Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy, MIM#\t619090"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "dJ68L15.3",
                    "CGI-129",
                    "SLC54A1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21606",
                "gene_name": "mitochondrial pyruvate carrier 1",
                "omim_gene": [
                    "614738"
                ],
                "alias_name": null,
                "gene_symbol": "MPC1",
                "hgnc_symbol": "MPC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:166778407-166796486",
                            "ensembl_id": "ENSG00000060762"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:166364919-166383013",
                            "ensembl_id": "ENSG00000060762"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-07-30"
            },
            "entity_type": "gene",
            "entity_name": "MPC1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22628558",
                "34873722"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mitochondrial pyruvate carrier deficiency, MIM# 614741"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SL15",
                    "Lec35",
                    "PQLC5",
                    "CDGIf"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7207",
                "gene_name": "mannose-P-dolichol utilization defect 1",
                "omim_gene": [
                    "604041"
                ],
                "alias_name": null,
                "gene_symbol": "MPDU1",
                "hgnc_symbol": "MPDU1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:7486847-7496107",
                            "ensembl_id": "ENSG00000129255"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:7583529-7592789",
                            "ensembl_id": "ENSG00000129255"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-05-25"
            },
            "entity_type": "gene",
            "entity_name": "MPDU1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11733564",
                "11733556",
                "31741824",
                "29721919"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Congenital disorder of glycosylation, type If, MIM# 609180",
                "MPDU1-CDG, MONDO:0012211"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MUPP1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7208",
                "gene_name": "multiple PDZ domain crumbs cell polarity complex component",
                "omim_gene": [
                    "603785"
                ],
                "alias_name": null,
                "gene_symbol": "MPDZ",
                "hgnc_symbol": "MPDZ",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:13105703-13279589",
                            "ensembl_id": "ENSG00000107186"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:13105704-13279590",
                            "ensembl_id": "ENSG00000107186"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-16"
            },
            "entity_type": "gene",
            "entity_name": "MPDZ",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28556411",
                "23240096",
                "30518636",
                "29499638"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Hydrocephalus, congenital, 2, with or without brain or eye anomalies, MIM# 615219"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7216",
                "gene_name": "mannose phosphate isomerase",
                "omim_gene": [
                    "154550"
                ],
                "alias_name": [
                    "mannose-6-phosphate isomerase"
                ],
                "gene_symbol": "MPI",
                "hgnc_symbol": "MPI",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:75182346-75191798",
                            "ensembl_id": "ENSG00000178802"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:74890005-74902219",
                            "ensembl_id": "ENSG00000178802"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "MPI",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12414827",
                "9585601",
                "10980531",
                "33098580",
                "33204592",
                "32905087",
                "32266963",
                "30242110"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Congenital disorder of glycosylation, type Ib, MIM# 602579",
                "MPI-CDG MONDO:0011257"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CD110",
                    "TPOR"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7217",
                "gene_name": "MPL proto-oncogene, thrombopoietin receptor",
                "omim_gene": [
                    "159530"
                ],
                "alias_name": null,
                "gene_symbol": "MPL",
                "hgnc_symbol": "MPL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:43803478-43818443",
                            "ensembl_id": "ENSG00000117400"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:43337849-43352772",
                            "ensembl_id": "ENSG00000117400"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-09-10"
            },
            "entity_type": "gene",
            "entity_name": "MPL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28955303",
                "26423830"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Myelofibrosis with myeloid metaplasia, somatic, MIM#254450",
                "Thrombocythemia 2, MIM#601977, AD, SMu",
                "Thrombocytopenia, congenital amegakaryocytic, MIM#604498, AR"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ORF20",
                    "TTDN1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16002",
                "gene_name": "M-phase specific PLK1 interacting protein",
                "omim_gene": [
                    "609188"
                ],
                "alias_name": null,
                "gene_symbol": "MPLKIP",
                "hgnc_symbol": "MPLKIP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:40165622-40174258",
                            "ensembl_id": "ENSG00000168303"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:40126023-40134659",
                            "ensembl_id": "ENSG00000168303"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-03-01"
            },
            "entity_type": "gene",
            "entity_name": "MPLKIP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15645389",
                "16977596"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Trichothiodystrophy 4, nonphotosensitive, MIM# 234050",
                "MONDO:0021013"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7218",
                "gene_name": "myeloperoxidase",
                "omim_gene": [
                    "606989"
                ],
                "alias_name": null,
                "gene_symbol": "MPO",
                "hgnc_symbol": "MPO",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:56347217-56358296",
                            "ensembl_id": "ENSG00000005381"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:58269856-58280935",
                            "ensembl_id": "ENSG00000005381"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "MPO",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Myeloperoxidase deficiency, MIM# 254600"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7221",
                "gene_name": "membrane palmitoylated protein 3",
                "omim_gene": [
                    "601114"
                ],
                "alias_name": [
                    "MAGUK p55 subfamily member 3",
                    "discs, large (Drosophila) homolog 3",
                    "membrane protein palmitoylated 3"
                ],
                "gene_symbol": "MPP3",
                "hgnc_symbol": "MPP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:41878167-41910538",
                            "ensembl_id": "ENSG00000161647"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:43800799-43833170",
                            "ensembl_id": "ENSG00000161647"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-05-04"
            },
            "entity_type": "gene",
            "entity_name": "MPP3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MST",
                    "TST2",
                    "TUM1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7223",
                "gene_name": "mercaptopyruvate sulfurtransferase",
                "omim_gene": [
                    "602496"
                ],
                "alias_name": [
                    "human liver rhodanese",
                    "tRNA thiouridin modification protein 1"
                ],
                "gene_symbol": "MPST",
                "hgnc_symbol": "MPST",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:37415676-37425863",
                            "ensembl_id": "ENSG00000128309"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:37019635-37029822",
                            "ensembl_id": "ENSG00000128309"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-05-22"
            },
            "entity_type": "gene",
            "entity_name": "MPST",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SYM1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7224",
                "gene_name": "MPV17, mitochondrial inner membrane protein",
                "omim_gene": [
                    "137960"
                ],
                "alias_name": [
                    "glomerulosclerosis"
                ],
                "gene_symbol": "MPV17",
                "hgnc_symbol": "MPV17",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:27532360-27548547",
                            "ensembl_id": "ENSG00000115204"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:27309492-27325680",
                            "ensembl_id": "ENSG00000115204"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-03-21"
            },
            "entity_type": "gene",
            "entity_name": "MPV17",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22508010",
                "26437932",
                "30298599"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Charcot-Marie-Tooth disease, axonal, type 2EE, MIM# 618400"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HMSNIB",
                    "CMT2I",
                    "CMT2J"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7225",
                "gene_name": "myelin protein zero",
                "omim_gene": [
                    "159440"
                ],
                "alias_name": null,
                "gene_symbol": "MPZ",
                "hgnc_symbol": "MPZ",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:161274525-161279762",
                            "ensembl_id": "ENSG00000158887"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:161304735-161309972",
                            "ensembl_id": "ENSG00000158887"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-04-27"
            },
            "entity_type": "gene",
            "entity_name": "MPZ",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19293842"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Charcot Marie Tooth disease, dominant intermediate D, 60779",
                "Neuropathy, congenital hypomyelinating, 605253",
                "Charcot Marie Tooth disease, type 2J, 607736",
                "Dejerine Sottas disease, 145900",
                "Charcot Marie Tooth disease, type 1B, 118200",
                "Charcot Marie Tooth disease, type 2I, 607677",
                "HMSN"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "EVA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3496",
                "gene_name": "myelin protein zero like 2",
                "omim_gene": [
                    "604873"
                ],
                "alias_name": null,
                "gene_symbol": "MPZL2",
                "hgnc_symbol": "MPZL2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:118124118-118135251",
                            "ensembl_id": "ENSG00000149573"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:118253403-118264536",
                            "ensembl_id": "ENSG00000149573"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-01"
            },
            "entity_type": "gene",
            "entity_name": "MPZL2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29982980",
                "29961571"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal recessive 111, MIM#618145"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "B27",
                    "FALP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1304",
                "gene_name": "melanocortin 2 receptor accessory protein",
                "omim_gene": [
                    "609196"
                ],
                "alias_name": null,
                "gene_symbol": "MRAP",
                "hgnc_symbol": "MRAP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "21:33664124-33687095",
                            "ensembl_id": "ENSG00000170262"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "21:32291813-32314784",
                            "ensembl_id": "ENSG00000170262"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-02-07"
            },
            "entity_type": "gene",
            "entity_name": "MRAP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15654338"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Glucocorticoid deficiency 2, MIM# 607398"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ATLD"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7230",
                "gene_name": "MRE11 homolog, double strand break repair nuclease",
                "omim_gene": [
                    "600814"
                ],
                "alias_name": [
                    "AT-like disease"
                ],
                "gene_symbol": "MRE11",
                "hgnc_symbol": "MRE11",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:94152895-94227074",
                            "ensembl_id": "ENSG00000020922"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:94415578-94493908",
                            "ensembl_id": "ENSG00000020922"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2016-09-30"
            },
            "entity_type": "gene",
            "entity_name": "MRE11",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10612394",
                "11371508",
                "15269180",
                "22863007",
                "24332946",
                "21227757"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ataxia-telangiectasia-like disorder 1, MIM# 604391",
                "MONDO:0024557"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRPL7/L12",
                    "MRPL7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10378",
                "gene_name": "mitochondrial ribosomal protein L12",
                "omim_gene": [
                    "602375"
                ],
                "alias_name": null,
                "gene_symbol": "MRPL12",
                "hgnc_symbol": "MRPL12",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:79670387-79674556",
                            "ensembl_id": "ENSG00000262814"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:81703357-81707526",
                            "ensembl_id": "ENSG00000262814"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-02-14"
            },
            "entity_type": "gene",
            "entity_name": "MRPL12",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23603806"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Growth retardation",
                "neurological deterioration",
                "mitochondrial translation deficiency",
                "Combined oxidative phosphorylation deficiency 45, MIM#618951"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRL3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10379",
                "gene_name": "mitochondrial ribosomal protein L3",
                "omim_gene": [
                    "607118"
                ],
                "alias_name": null,
                "gene_symbol": "MRPL3",
                "hgnc_symbol": "MRPL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:131181056-131221827",
                            "ensembl_id": "ENSG00000114686"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:131462212-131502983",
                            "ensembl_id": "ENSG00000114686"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-09-16"
            },
            "entity_type": "gene",
            "entity_name": "MRPL3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27815843",
                "21786366"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services",
                "Australian Genomics Health Alliance Mitochondrial Flagship",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 9",
                "OMIM #614582"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ12701",
                    "FLJ13990"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16650",
                "gene_name": "mitochondrial ribosomal protein L44",
                "omim_gene": [
                    "611849"
                ],
                "alias_name": [
                    "39S ribosomal protein L44, mitochondrial"
                ],
                "gene_symbol": "MRPL44",
                "hgnc_symbol": "MRPL44",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:224822121-224832431",
                            "ensembl_id": "ENSG00000135900"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:223957404-223967714",
                            "ensembl_id": "ENSG00000135900"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-10-12"
            },
            "entity_type": "gene",
            "entity_name": "MRPL44",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23315540",
                "25797485"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 16, MIM# 615395"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA2004",
                    "FLJ20073"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1348",
                "gene_name": "sterile alpha motif domain containing 9",
                "omim_gene": [
                    "610456"
                ],
                "alias_name": null,
                "gene_symbol": "SAMD9",
                "hgnc_symbol": "SAMD9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:92728829-92747336",
                            "ensembl_id": "ENSG00000205413"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:93099513-93118023",
                            "ensembl_id": "ENSG00000205413"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-07-16"
            },
            "entity_type": "gene",
            "entity_name": "SAMD9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "33237688",
                "32619790",
                "16960814",
                "18094730"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "MIRAGE syndrome, MIM#617053",
                "Tumoral calcinosis, familial, normophosphatemic, MIM#610455",
                "Monosomy 7 myelodysplasia and leukemia syndrome 2, MIM# 619041"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGI-132"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14048",
                "gene_name": "mitochondrial ribosomal protein S16",
                "omim_gene": [
                    "609204"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS16",
                "hgnc_symbol": "MRPS16",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:75006510-75012451",
                            "ensembl_id": "ENSG00000182180"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:73248843-73252693",
                            "ensembl_id": "ENSG00000182180"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-02-28"
            },
            "entity_type": "gene",
            "entity_name": "MRPS16",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28749478",
                "15505824"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services",
                "Australian Genomics Health Alliance Mitochondrial Flagship",
                "Victorian Clinical Genetics Services",
                "Australian Genomcis Health Alliance Leukodystrophy Flagship",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 2",
                "OMIM #610498"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "dJ1112F19.1",
                    "ZNF797"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15924",
                "gene_name": "spalt like transcription factor 4",
                "omim_gene": [
                    "607343"
                ],
                "alias_name": null,
                "gene_symbol": "SALL4",
                "hgnc_symbol": "SALL4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:50400581-50419059",
                            "ensembl_id": "ENSG00000101115"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:51782331-51802520",
                            "ensembl_id": "ENSG00000101115"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-21"
            },
            "entity_type": "gene",
            "entity_name": "SALL4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20301547"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Duane-radial ray syndrome, MIM# 607323",
                "MONDO:0011812",
                "IVIC syndrome, MIM# 147750",
                "MONDO:0007836"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ZNF796"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10527",
                "gene_name": "spalt like transcription factor 3",
                "omim_gene": [
                    "605079"
                ],
                "alias_name": null,
                "gene_symbol": "SALL3",
                "hgnc_symbol": "SALL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:76740275-76762677",
                            "ensembl_id": "ENSG00000256463"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:78980275-79002677",
                            "ensembl_id": "ENSG00000256463"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-01-20"
            },
            "entity_type": "gene",
            "entity_name": "SALL3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Hsal1",
                    "ZNF794"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10524",
                "gene_name": "spalt like transcription factor 1",
                "omim_gene": [
                    "602218"
                ],
                "alias_name": null,
                "gene_symbol": "SALL1",
                "hgnc_symbol": "SALL1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:51169886-51185278",
                            "ensembl_id": "ENSG00000103449"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:51135975-51151367",
                            "ensembl_id": "ENSG00000103449"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1996-10-11"
            },
            "entity_type": "gene",
            "entity_name": "SALL1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Townes-Brocks syndrome 1, MIM#107480",
                "MONDO:0054581"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ARRESTIN",
                    "RP47"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10521",
                "gene_name": "S-antigen visual arrestin",
                "omim_gene": [
                    "181031"
                ],
                "alias_name": [
                    "arrestin 1",
                    "rod arrestin"
                ],
                "gene_symbol": "SAG",
                "hgnc_symbol": "SAG",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:234216462-234255701",
                            "ensembl_id": "ENSG00000130561"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:233307816-233347055",
                            "ensembl_id": "ENSG00000130561"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-09-19"
            },
            "entity_type": "gene",
            "entity_name": "SAG",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "7670478",
                "9565049",
                "15234147",
                "28549094",
                "33047631",
                "9565049",
                "31257036"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Oguchi disease-1, MIM# 258100",
                "Retinitis pigmentosa 47, autosomal recessive MIM# 613758",
                "Retinitis pigmentosa 96, autosomal dominant, MIM# 620228"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ARSACS",
                    "KIAA0730",
                    "DKFZp686B15167",
                    "DNAJC29",
                    "SPAX6",
                    "PPP1R138"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10519",
                "gene_name": "sacsin molecular chaperone",
                "omim_gene": [
                    "604490"
                ],
                "alias_name": [
                    "protein phosphatase 1, regulatory subunit 138"
                ],
                "gene_symbol": "SACS",
                "hgnc_symbol": "SACS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:23902965-24007841",
                            "ensembl_id": "ENSG00000151835"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:23328826-23411513",
                            "ensembl_id": "ENSG00000151835"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-11-19"
            },
            "entity_type": "gene",
            "entity_name": "SACS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spastic ataxia, Charlevoix-Saguenay type MIM#270550"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Gpcr13",
                    "H218",
                    "AGR16"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3169",
                "gene_name": "sphingosine-1-phosphate receptor 2",
                "omim_gene": [
                    "605111"
                ],
                "alias_name": null,
                "gene_symbol": "S1PR2",
                "hgnc_symbol": "S1PR2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:10334520-10341948",
                            "ensembl_id": "ENSG00000267534"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:10221435-10231272",
                            "ensembl_id": "ENSG00000267534"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-04-30"
            },
            "entity_type": "gene",
            "entity_name": "S1PR2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26805784",
                "29776397",
                "27383011"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal recessive 68, MIM# 610419"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RYR",
                    "PPP1R137"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10483",
                "gene_name": "ryanodine receptor 1",
                "omim_gene": [
                    "180901"
                ],
                "alias_name": [
                    "protein phosphatase 1, regulatory subunit 137"
                ],
                "gene_symbol": "RYR1",
                "hgnc_symbol": "RYR1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:38924339-39078204",
                            "ensembl_id": "ENSG00000196218"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:38433699-38587564",
                            "ensembl_id": "ENSG00000196218"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-12-01"
            },
            "entity_type": "gene",
            "entity_name": "RYR1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20301325"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "{Malignant hyperthermia susceptibility 1} MIM#145600",
                "Central core disease, MIM# 117000",
                "King-Denborough syndrome , MIM#619542",
                "Minicore myopathy with external ophthalmoplegia , MIM#255320",
                "Neuromuscular disease, congenital, with uniform type 1 fiber, MIM# 117000"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HP10481"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13530",
                "gene_name": "transmembrane protein 5",
                "omim_gene": [
                    "605862"
                ],
                "alias_name": null,
                "gene_symbol": "TMEM5",
                "hgnc_symbol": "TMEM5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:64173583-64203338",
                            "ensembl_id": "ENSG00000118600"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:63779803-63809558",
                            "ensembl_id": "ENSG00000118600"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-09-20"
            },
            "entity_type": "gene",
            "entity_name": "TMEM5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23217329",
                "23519211"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, MIM# 615041"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGI-91"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14495",
                "gene_name": "mitochondrial ribosomal protein S2",
                "omim_gene": [
                    "611971"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS2",
                "hgnc_symbol": "MRPS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:138391830-138396519",
                            "ensembl_id": "ENSG00000122140"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:135499984-135504673",
                            "ensembl_id": "ENSG00000122140"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-26"
            },
            "entity_type": "gene",
            "entity_name": "MRPS2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29576219",
                "34991560"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 36, MIM# 617950"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GREAT",
                    "GPR106",
                    "INSL3R",
                    "RXFPR2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17318",
                "gene_name": "relaxin/insulin like family peptide receptor 2",
                "omim_gene": [
                    "606655"
                ],
                "alias_name": null,
                "gene_symbol": "RXFP2",
                "hgnc_symbol": "RXFP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:32313674-32377009",
                            "ensembl_id": "ENSG00000133105"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:31739542-31803388",
                            "ensembl_id": "ENSG00000133105"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-09"
            },
            "entity_type": "gene",
            "entity_name": "RXFP2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31167797",
                "20963592",
                "37208861",
                "38430325",
                "39222519"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Infertility",
                "cryptorchidism",
                "non-obstructive azoospermia"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0375"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23625",
                "gene_name": "RUN and SH3 domain containing 2",
                "omim_gene": [
                    "611053"
                ],
                "alias_name": null,
                "gene_symbol": "RUSC2",
                "hgnc_symbol": "RUSC2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:35490124-35561895",
                            "ensembl_id": "ENSG00000198853"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:35490127-35561898",
                            "ensembl_id": "ENSG00000198853"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-12-02"
            },
            "entity_type": "gene",
            "entity_name": "RUSC2",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "36553572",
                "27612186"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Intellectual developmental disorder, autosomal recessive 61 MIM#617773"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "AML3",
                    "PEBP2A1",
                    "PEBP2aA1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10472",
                "gene_name": "runt related transcription factor 2",
                "omim_gene": [
                    "600211"
                ],
                "alias_name": null,
                "gene_symbol": "RUNX2",
                "hgnc_symbol": "RUNX2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:45295894-45632086",
                            "ensembl_id": "ENSG00000124813"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:45328157-45664349",
                            "ensembl_id": "ENSG00000124813"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-11-02"
            },
            "entity_type": "gene",
            "entity_name": "RUNX2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20301686"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Cleidocranial dysplasia MIM#119600",
                "Cleidocranial dysplasia, forme fruste, dental anomalies only MIM#119600",
                "Cleidocranial dysplasia, forme fruste, with brachydactyly MIM#119600",
                "Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly MIM#156510"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PEBP2A2",
                    "AMLCR1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10471",
                "gene_name": "runt related transcription factor 1",
                "omim_gene": [
                    "151385"
                ],
                "alias_name": [
                    "aml1 oncogene"
                ],
                "gene_symbol": "RUNX1",
                "hgnc_symbol": "RUNX1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "21:36160098-37376965",
                            "ensembl_id": "ENSG00000159216"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "21:34787801-36004667",
                            "ensembl_id": "ENSG00000159216"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-08-20"
            },
            "entity_type": "gene",
            "entity_name": "RUNX1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10508512",
                "11830488"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Platelet disorder, familial, with associated myeloid malignancy, MIM# 601399",
                "Leukemia, acute myeloid, MIM# 601626"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "rubicon",
                    "rundataxin"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28991",
                "gene_name": "RUN and cysteine rich domain containing beclin 1 interacting protein",
                "omim_gene": [
                    "613516"
                ],
                "alias_name": [
                    "RUN domain and cysteine-rich domain containing",
                    "Beclin 1-interacting protein"
                ],
                "gene_symbol": "RUBCN",
                "hgnc_symbol": "RUBCN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:197398264-197476598",
                            "ensembl_id": "ENSG00000145016"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:197671393-197749727",
                            "ensembl_id": "ENSG00000145016"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-10-16"
            },
            "entity_type": "gene",
            "entity_name": "RUBCN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20826435",
                "30237576"
            ],
            "evidence": [
                "Expert Review Green",
                "Royal Melbourne Hospital",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services",
                "Royal Melbourne Hospital Clinical Genetics Department"
            ],
            "phenotypes": [
                "Spinocerebellar ataxia, autosomal recessive 15, MIM#615705"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZP434G145"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18654",
                "gene_name": "rotatin",
                "omim_gene": [
                    "610436"
                ],
                "alias_name": null,
                "gene_symbol": "RTTN",
                "hgnc_symbol": "RTTN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "18:67671029-67873181",
                            "ensembl_id": "ENSG00000176225"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "18:70003031-70205945",
                            "ensembl_id": "ENSG00000176225"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-07-11"
            },
            "entity_type": "gene",
            "entity_name": "RTTN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "30879067"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Microcephaly, short stature, and polymicrogyria with seizures, MIM#\t614833",
                "microcephalic primordial dwarfism due to RTTN deficiency MONDO:0018764"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NIMP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18647",
                "gene_name": "reticulon 4 interacting protein 1",
                "omim_gene": [
                    "610502"
                ],
                "alias_name": null,
                "gene_symbol": "RTN4IP1",
                "hgnc_symbol": "RTN4IP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:107018903-107077373",
                            "ensembl_id": "ENSG00000130347"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:106571971-106629487",
                            "ensembl_id": "ENSG00000130347"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-23"
            },
            "entity_type": "gene",
            "entity_name": "RTN4IP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26593267",
                "31077085"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Optic atrophy 10 with or without ataxia, mental retardation, and seizures, MIM#616732"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP-S22",
                    "GK002",
                    "C3orf5",
                    "GIBT"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14508",
                "gene_name": "mitochondrial ribosomal protein S22",
                "omim_gene": [
                    "605810"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS22",
                "hgnc_symbol": "MRPS22",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:138724648-139076065",
                            "ensembl_id": "ENSG00000175110"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:139005806-139357223",
                            "ensembl_id": "ENSG00000175110"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-26"
            },
            "entity_type": "gene",
            "entity_name": "MRPS22",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29566152"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 5 MIM#611719",
                "Ovarian dysgenesis 7 MIM#618117"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NSP2",
                    "NSPL1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10468",
                "gene_name": "reticulon 2",
                "omim_gene": [
                    "603183"
                ],
                "alias_name": [
                    "NSP-like protein 1",
                    "Neuroendocrine-specific protein-like 1"
                ],
                "gene_symbol": "RTN2",
                "hgnc_symbol": "RTN2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:45988547-46000319",
                            "ensembl_id": "ENSG00000125744"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:45485289-45497061",
                            "ensembl_id": "ENSG00000125744"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-07-01"
            },
            "entity_type": "gene",
            "entity_name": "RTN2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22232211",
                "27165006",
                "38527963"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spastic paraplegia 12, autosomal dominant, 604805",
                "MONDO:0011489",
                "Neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity, MIM# 620854"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "bK3184A7.3",
                    "NHL",
                    "DKFZP434C013",
                    "KIAA1088",
                    "RTEL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15888",
                "gene_name": "regulator of telomere elongation helicase 1",
                "omim_gene": [
                    "608833"
                ],
                "alias_name": null,
                "gene_symbol": "RTEL1",
                "hgnc_symbol": "RTEL1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:62289163-62328416",
                            "ensembl_id": "ENSG00000258366"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:63657810-63696253",
                            "ensembl_id": "ENSG00000258366"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-10-29"
            },
            "entity_type": "gene",
            "entity_name": "RTEL1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20301779",
                "23329068",
                "15210109",
                "23453664",
                "19461895",
                "25848748",
                "25607374"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Dyskeratosis congenita, autosomal dominant 4 MIM# 615190",
                "Dyskeratosis congenita, autosomal recessive 5 MIM# 615190",
                "Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 MIM# 616373"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1972"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29420",
                "gene_name": "ring finger and SPRY domain containing 1",
                "omim_gene": [
                    "616585"
                ],
                "alias_name": null,
                "gene_symbol": "RSPRY1",
                "hgnc_symbol": "RSPRY1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:57220049-57274387",
                            "ensembl_id": "ENSG00000159579"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:57186137-57240475",
                            "ensembl_id": "ENSG00000159579"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-02-17"
            },
            "entity_type": "gene",
            "entity_name": "RSPRY1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26365341",
                "30063090",
                "38562122",
                "39940902"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, MIM# 616723"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "dJ824F16.3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16175",
                "gene_name": "R-spondin 4",
                "omim_gene": [
                    "610573"
                ],
                "alias_name": null,
                "gene_symbol": "RSPO4",
                "hgnc_symbol": "RSPO4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:939095-982907",
                            "ensembl_id": "ENSG00000101282"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:958452-1002264",
                            "ensembl_id": "ENSG00000101282"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-08-08"
            },
            "entity_type": "gene",
            "entity_name": "RSPO4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "17041604",
                "17914448",
                "18070203"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Anonychia congenita MIM# 206800"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC35555"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28583",
                "gene_name": "R-spondin 2",
                "omim_gene": [
                    "610575"
                ],
                "alias_name": null,
                "gene_symbol": "RSPO2",
                "hgnc_symbol": "RSPO2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:108911544-109095913",
                            "ensembl_id": "ENSG00000147655"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:107899316-108083648",
                            "ensembl_id": "ENSG00000147655"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-08-08"
            },
            "entity_type": "gene",
            "entity_name": "RSPO2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29769720",
                "32457899"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Tetraamelia syndrome 2, MIM# 618021"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ40906",
                    "RSPONDIN"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21679",
                "gene_name": "R-spondin 1",
                "omim_gene": [
                    "609595"
                ],
                "alias_name": null,
                "gene_symbol": "RSPO1",
                "hgnc_symbol": "RSPO1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:38076951-38100595",
                            "ensembl_id": "ENSG00000169218"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:37611350-37634923",
                            "ensembl_id": "ENSG00000169218"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-08-08"
            },
            "entity_type": "gene",
            "entity_name": "RSPO1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "17041600",
                "18085567",
                "18250098",
                "18250097"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal MIM#610644",
                "Palmoplantar hyperkeratosis and true hermaphroditism MIM#610644"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ30845",
                    "CILD12"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21057",
                "gene_name": "radial spoke head 9 homolog",
                "omim_gene": [
                    "612648"
                ],
                "alias_name": null,
                "gene_symbol": "RSPH9",
                "hgnc_symbol": "RSPH9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:43612783-43640336",
                            "ensembl_id": "ENSG00000172426"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:43645046-43672599",
                            "ensembl_id": "ENSG00000172426"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-02-17"
            },
            "entity_type": "gene",
            "entity_name": "RSPH9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25789548",
                "22384920",
                "23993197",
                "19200523",
                "27626380"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ciliary dyskinesia, primary, 12, MIM#612650"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "dJ412I7.1",
                    "FLJ37974",
                    "RSPH6B",
                    "CILD11"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21558",
                "gene_name": "radial spoke head 4 homolog A",
                "omim_gene": [
                    "612647"
                ],
                "alias_name": null,
                "gene_symbol": "RSPH4A",
                "hgnc_symbol": "RSPH4A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:116937642-116954148",
                            "ensembl_id": "ENSG00000111834"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:116616479-116632985",
                            "ensembl_id": "ENSG00000111834"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-02-17"
            },
            "entity_type": "gene",
            "entity_name": "RSPH4A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23798057",
                "23798057",
                "23798057",
                "25789548",
                "22448264"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ciliary dyskinesia, primary, 11, OMIM#612649"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP-S23",
                    "CGI-138",
                    "HSPC329"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14509",
                "gene_name": "mitochondrial ribosomal protein S23",
                "omim_gene": [
                    "611985"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS23",
                "hgnc_symbol": "MRPS23",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:55916842-55927417",
                            "ensembl_id": "ENSG00000181610"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:57834781-57850056",
                            "ensembl_id": "ENSG00000181610"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-26"
            },
            "entity_type": "gene",
            "entity_name": "MRPS23",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26741492",
                "17873122",
                "25663021",
                "28752220"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Hepatic disease",
                "Combined respiratory chain complex deficiencies",
                "Hepatic disease",
                "Combined respiratory chain complex deficiencies",
                "Cardiomyopathy",
                "Tubulopathy",
                "Lactic acidosis",
                "Structural brain abnormalities",
                "Combined oxidative phosphorylation deficiency 45, MIM#618951"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP-S12",
                    "MGC2616"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16618",
                "gene_name": "mitochondrial ribosomal protein S34",
                "omim_gene": [
                    "611994"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS34",
                "hgnc_symbol": "MRPS34",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:1821891-1823156",
                            "ensembl_id": "ENSG00000074071"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:1771890-1773155",
                            "ensembl_id": "ENSG00000074071"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-09-18"
            },
            "entity_type": "gene",
            "entity_name": "MRPS34",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28777931"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 32, 61766"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP-S",
                    "RP-S7",
                    "RPMS7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14499",
                "gene_name": "mitochondrial ribosomal protein S7",
                "omim_gene": [
                    "611974"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS7",
                "hgnc_symbol": "MRPS7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:73257755-73262454",
                            "ensembl_id": "ENSG00000125445"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:75261674-75266373",
                            "ensembl_id": "ENSG00000125445"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-26"
            },
            "entity_type": "gene",
            "entity_name": "MRPS7",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25556185",
                "36421788"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 34, MIM# 617872"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "B1",
                    "Bp35",
                    "MS4A2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7315",
                "gene_name": "membrane spanning 4-domains A1",
                "omim_gene": [
                    "112210"
                ],
                "alias_name": null,
                "gene_symbol": "MS4A1",
                "hgnc_symbol": "MS4A1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:60223225-60238233",
                            "ensembl_id": "ENSG00000156738"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:60455752-60470760",
                            "ensembl_id": "ENSG00000156738"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-05-23"
            },
            "entity_type": "gene",
            "entity_name": "MS4A1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20038800",
                "23966626",
                "32048120"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency, common variable, 5, MIM# 613495"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DUP",
                    "MRP1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7326",
                "gene_name": "mutS homolog 3",
                "omim_gene": [
                    "600887"
                ],
                "alias_name": [
                    "Divergent upstream protein",
                    "Mismatch repair protein 1"
                ],
                "gene_symbol": "MSH3",
                "hgnc_symbol": "MSH3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:79950467-80172279",
                            "ensembl_id": "ENSG00000113318"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:80654648-80876460",
                            "ensembl_id": "ENSG00000113318"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-09-28"
            },
            "entity_type": "gene",
            "entity_name": "MSH3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27476653",
                "10706084",
                "34843512"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Familial adenomatous polyposis 4 , MIM#617100"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7370",
                "gene_name": "MSL complex subunit 3",
                "omim_gene": [
                    "300609"
                ],
                "alias_name": null,
                "gene_symbol": "MSL3",
                "hgnc_symbol": "MSL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:11776278-11793870",
                            "ensembl_id": "ENSG00000005302"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:11758159-11775753",
                            "ensembl_id": "ENSG00000005302"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-10-29"
            },
            "entity_type": "gene",
            "entity_name": "MSL3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "33173220"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Basilicata-Akhtar syndrome, OMIM # 301032"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PSP-94",
                    "PSP57",
                    "PSP94",
                    "IGBF",
                    "MSP",
                    "MSPB",
                    "PN44",
                    "PRPS",
                    "PSP"
                ],
                "biotype": null,
                "hgnc_id": "HGNC:7372",
                "gene_name": "microseminoprotein beta",
                "omim_gene": [
                    "157145"
                ],
                "alias_name": [
                    "beta-microseminoprotein"
                ],
                "gene_symbol": "MSMB",
                "hgnc_symbol": "MSMB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:51549498-51562517",
                            "ensembl_id": "ENSG00000138294"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:46033307-46046269",
                            "ensembl_id": "ENSG00000263639"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-08-07"
            },
            "entity_type": "gene",
            "entity_name": "MSMB",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "{Prostate cancer, hereditary, 13} 611928"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DESP4",
                    "ERG25"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10545",
                "gene_name": "methylsterol monooxygenase 1",
                "omim_gene": [
                    "607545"
                ],
                "alias_name": null,
                "gene_symbol": "MSMO1",
                "hgnc_symbol": "MSMO1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:166248775-166264312",
                            "ensembl_id": "ENSG00000052802"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:165327623-165343160",
                            "ensembl_id": "ENSG00000052802"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-09-01"
            },
            "entity_type": "gene",
            "entity_name": "MSMO1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27604308",
                "21285510",
                "24144731",
                "33161406",
                "28673550",
                "33161406"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Microcephaly, congenital cataract, and psoriasiform dermatitis, MIM# 616834",
                "MONDO:0014793",
                "Disorders of the metabolism of sterols"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7373",
                "gene_name": "moesin",
                "omim_gene": [
                    "309845"
                ],
                "alias_name": null,
                "gene_symbol": "MSN",
                "hgnc_symbol": "MSN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:64808257-64961791",
                            "ensembl_id": "ENSG00000147065"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:65588377-65741931",
                            "ensembl_id": "ENSG00000147065"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-02-05"
            },
            "entity_type": "gene",
            "entity_name": "MSN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27405666"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 50, MIM# 300988"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SCARA1",
                    "CD204",
                    "SR-AI",
                    "SR-AII",
                    "SR-AIII",
                    "SR-A"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7376",
                "gene_name": "macrophage scavenger receptor 1",
                "omim_gene": [
                    "153622"
                ],
                "alias_name": null,
                "gene_symbol": "MSR1",
                "hgnc_symbol": "MSR1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:15965387-16424999",
                            "ensembl_id": "ENSG00000038945"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:16107878-16567490",
                            "ensembl_id": "ENSG00000038945"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-08-07"
            },
            "entity_type": "gene",
            "entity_name": "MSR1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12958598",
                "21791690"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Barrett esophagus/esophageal adenocarcinoma, MIM# 614266"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ36866",
                    "DKFZp686C1178"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:27375",
                "gene_name": "methionine sulfoxide reductase B3",
                "omim_gene": [
                    "613719"
                ],
                "alias_name": null,
                "gene_symbol": "MSRB3",
                "hgnc_symbol": "MSRB3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:65672423-65882024",
                            "ensembl_id": "ENSG00000174099"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:65278643-65488244",
                            "ensembl_id": "ENSG00000174099"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-12-06"
            },
            "entity_type": "gene",
            "entity_name": "MSRB3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19650862",
                "24191262",
                "21185009"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal recessive 74, MIM# 613718"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4223",
                "gene_name": "myostatin",
                "omim_gene": [
                    "601788"
                ],
                "alias_name": null,
                "gene_symbol": "MSTN",
                "hgnc_symbol": "MSTN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:190920423-190927455",
                            "ensembl_id": "ENSG00000138379"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:190055697-190062729",
                            "ensembl_id": "ENSG00000138379"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-06-21"
            },
            "entity_type": "gene",
            "entity_name": "MSTN",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15215484"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Muscle hypertrophy, MIM# 614160"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ10504",
                    "LST005",
                    "MST",
                    "misato"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29678",
                "gene_name": "misato 1, mitochondrial distribution and morphology regulator",
                "omim_gene": [
                    "617619"
                ],
                "alias_name": null,
                "gene_symbol": "MSTO1",
                "hgnc_symbol": "MSTO1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:155579979-155718153",
                            "ensembl_id": "ENSG00000125459"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:155610205-155614967",
                            "ensembl_id": "ENSG00000125459"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-07-19"
            },
            "entity_type": "gene",
            "entity_name": "MSTO1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28554942",
                "28544275",
                "31604776",
                "31463572",
                "31130378",
                "30684668",
                "29339779"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Myopathy, mitochondrial, and ataxia, OMIM:617675",
                "Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, MONDO:0044714"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HYD1",
                    "OFC5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7391",
                "gene_name": "msh homeobox 1",
                "omim_gene": [
                    "142983"
                ],
                "alias_name": null,
                "gene_symbol": "MSX1",
                "hgnc_symbol": "MSX1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:4861393-4865663",
                            "ensembl_id": "ENSG00000163132"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:4859666-4863936",
                            "ensembl_id": "ENSG00000163132"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-05-26"
            },
            "entity_type": "gene",
            "entity_name": "MSX1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "33419968",
                "33708320",
                "32192766"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Witkop syndrome (Ectodermal Dysplasia) (MIM: 189500),Cleft Lip+/- Cleft Palate (Rofacial Cleft- MIM :608874), Oligodontia"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CRS2",
                    "FPP",
                    "HOX8",
                    "MSH",
                    "PFM"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7392",
                "gene_name": "msh homeobox 2",
                "omim_gene": [
                    "123101"
                ],
                "alias_name": [
                    "craniosynostosis, type 2"
                ],
                "gene_symbol": "MSX2",
                "hgnc_symbol": "MSX2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:174151536-174157896",
                            "ensembl_id": "ENSG00000120149"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:174724533-174730893",
                            "ensembl_id": "ENSG00000120149"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-05-26"
            },
            "entity_type": "gene",
            "entity_name": "MSX2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23949913",
                "27884935",
                "23918290",
                "2359311",
                "22948472",
                "19533795",
                "10742103",
                "14571277"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Craniosynostosis 2 (MIM#604757)",
                "Parietal foramina 1 (MIM#168500)",
                "Parietal foramina with cleidocranial dysplasia (MIM#168550)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "trnP"
                ],
                "biotype": "Mt_tRNA",
                "hgnc_id": "HGNC:7494",
                "gene_name": "mitochondrially encoded tRNA proline",
                "omim_gene": [
                    "590075"
                ],
                "alias_name": null,
                "gene_symbol": "MT-TP",
                "hgnc_symbol": "MT-TP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "MT:15956-16023",
                            "ensembl_id": "ENSG00000210196"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "MT:15956-16023",
                            "ensembl_id": "ENSG00000210196"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-02-16"
            },
            "entity_type": "gene",
            "entity_name": "MT-TP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "7689388",
                "11196116",
                "19223931",
                "23696415",
                "19273760",
                "27536729",
                "27816331",
                "32305257",
                "32419253"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mitochondrial disease (MONDO:0044970), MT-TP-related"
            ],
            "mode_of_inheritance": "MITOCHONDRIAL",
            "tags": [
                "mtDNA"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MSAP",
                    "c86fus"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7413",
                "gene_name": "methylthioadenosine phosphorylase",
                "omim_gene": [
                    "156540"
                ],
                "alias_name": [
                    "S-methyl-5'-thioadenosine phosphorylase"
                ],
                "gene_symbol": "MTAP",
                "hgnc_symbol": "MTAP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:21802542-21931646",
                            "ensembl_id": "ENSG00000099810"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:21802543-21937651",
                            "ensembl_id": "ENSG00000099810"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "MTAP",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22464254"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Diaphyseal medullary stenosis with malignant fibrous histiocytoma, MIM# 112250"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FMT1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29666",
                "gene_name": "mitochondrial methionyl-tRNA formyltransferase",
                "omim_gene": [
                    "611766"
                ],
                "alias_name": null,
                "gene_symbol": "MTFMT",
                "hgnc_symbol": "MTFMT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:65294845-65321977",
                            "ensembl_id": "ENSG00000103707"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:65001512-65029639",
                            "ensembl_id": "ENSG00000103707"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-08-09"
            },
            "entity_type": "gene",
            "entity_name": "MTFMT",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21907147",
                "23499752",
                "24461907",
                "22499348"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 15, MIM# 614947",
                "Mitochondrial complex I deficiency, nuclear type 27, MIM# 618248"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7432",
                "gene_name": "methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",
                "omim_gene": [
                    "172460"
                ],
                "alias_name": null,
                "gene_symbol": "MTHFD1",
                "hgnc_symbol": "MTHFD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:64854749-64926722",
                            "ensembl_id": "ENSG00000100714"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:64388031-64463457",
                            "ensembl_id": "ENSG00000100714"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-07-23"
            },
            "entity_type": "gene",
            "entity_name": "MTHFD1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32414565",
                "19033438"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinaemia MIM # 617780"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7436",
                "gene_name": "methylenetetrahydrofolate reductase",
                "omim_gene": [
                    "607093"
                ],
                "alias_name": null,
                "gene_symbol": "MTHFR",
                "hgnc_symbol": "MTHFR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:11845780-11866977",
                            "ensembl_id": "ENSG00000177000"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:11785723-11806920",
                            "ensembl_id": "ENSG00000177000"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-07-15"
            },
            "entity_type": "gene",
            "entity_name": "MTHFR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27604308",
                "7920641"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Homocystinuria due to MTHFR deficiency MIM#236250",
                "Disorders of folate metabolism and transport"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7448",
                "gene_name": "myotubularin 1",
                "omim_gene": [
                    "300415"
                ],
                "alias_name": null,
                "gene_symbol": "MTM1",
                "hgnc_symbol": "MTM1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:149737069-149841795",
                            "ensembl_id": "ENSG00000171100"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:150568619-150673322",
                            "ensembl_id": "ENSG00000171100"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "MTM1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10790201"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Myopathy, centronuclear, X-linked, MIM# 310400"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ22405",
                    "FLJ90311",
                    "hJumpy",
                    "hEDTP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26190",
                "gene_name": "myotubularin related protein 14",
                "omim_gene": [
                    "611089"
                ],
                "alias_name": [
                    "egg-derived tyrosine phosphatase homolog (Drosophila)"
                ],
                "gene_symbol": "MTMR14",
                "hgnc_symbol": "MTMR14",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:9691117-9744077",
                            "ensembl_id": "ENSG00000163719"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:9649433-9702393",
                            "ensembl_id": "ENSG00000163719"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-12-18"
            },
            "entity_type": "gene",
            "entity_name": "MTMR14",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20400459",
                "20817957",
                "19465920",
                "17008356"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1073"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7450",
                "gene_name": "myotubularin related protein 2",
                "omim_gene": [
                    "603557"
                ],
                "alias_name": [
                    "phosphatidylinositol-3-phosphatase",
                    "phosphoinositide-3-phosphatase"
                ],
                "gene_symbol": "MTMR2",
                "hgnc_symbol": "MTMR2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:95566046-95658479",
                            "ensembl_id": "ENSG00000087053"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:95832882-95925315",
                            "ensembl_id": "ENSG00000087053"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-02-05"
            },
            "entity_type": "gene",
            "entity_name": "MTMR2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10802647",
                "16249189",
                "33653949",
                "32586600",
                "32488727",
                "31680794"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Charcot-Marie-Tooth disease, type 4B1, 601382",
                "MONDO:0011066"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19261",
                "gene_name": "mitochondrial tRNA translation optimization 1",
                "omim_gene": [
                    "614667"
                ],
                "alias_name": null,
                "gene_symbol": "MTO1",
                "hgnc_symbol": "MTO1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:74171301-74218959",
                            "ensembl_id": "ENSG00000135297"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:73461578-73509236",
                            "ensembl_id": "ENSG00000135297"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-05-21"
            },
            "entity_type": "gene",
            "entity_name": "MTO1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26061759",
                "29331171",
                "23929671"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Combined oxidative phosphorylation deficiency 10, OMIM #614702"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RAFT1",
                    "RAPT1",
                    "FLJ44809"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3942",
                "gene_name": "mechanistic target of rapamycin kinase",
                "omim_gene": [
                    "601231"
                ],
                "alias_name": [
                    "FK506 binding protein 12-rapamycin associated protein 2",
                    "rapamycin target protein",
                    "FKBP12-rapamycin complex-associated protein 1",
                    "FKBP-rapamycin associated protein",
                    "rapamycin associated protein FRAP2",
                    "dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)",
                    "rapamycin and FKBP12 target 1",
                    "mammalian target of rapamycin"
                ],
                "gene_symbol": "MTOR",
                "hgnc_symbol": "MTOR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:11166592-11322564",
                            "ensembl_id": "ENSG00000198793"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:11106535-11262507",
                            "ensembl_id": "ENSG00000198793"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-05-29"
            },
            "entity_type": "gene",
            "entity_name": "MTOR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "28892148",
                "25878179",
                "26018084"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Smith-Kingsmore syndrome, MIM# 616638",
                "Focal cortical dysplasia, type II, somatic, MIM# 607341",
                "Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, MONDO:0100283"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ10486",
                    "mtPAP",
                    "SPAX4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25532",
                "gene_name": "mitochondrial poly(A) polymerase",
                "omim_gene": [
                    "613669"
                ],
                "alias_name": [
                    "TUTase1"
                ],
                "gene_symbol": "MTPAP",
                "hgnc_symbol": "MTPAP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:30598730-30663377",
                            "ensembl_id": "ENSG00000107951"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:30309801-30374448",
                            "ensembl_id": "ENSG00000107951"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-01-12"
            },
            "entity_type": "gene",
            "entity_name": "MTPAP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20970105",
                "25008111",
                "26319014",
                "31779033"
            ],
            "evidence": [
                "Expert Review Green",
                "Royal Melbourne Hospital",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spastic ataxia 4, autosomal recessive 613672",
                "Lethal encephalopathy"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "founder"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "cblG"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7468",
                "gene_name": "5-methyltetrahydrofolate-homocysteine methyltransferase",
                "omim_gene": [
                    "156570"
                ],
                "alias_name": null,
                "gene_symbol": "MTR",
                "hgnc_symbol": "MTR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:236958610-237067281",
                            "ensembl_id": "ENSG00000116984"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:236795281-236903981",
                            "ensembl_id": "ENSG00000116984"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "MTR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "8968736",
                "8968737",
                "9683607",
                "12068375",
                "8968735",
                "27604308"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "cblE"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7473",
                "gene_name": "5-methyltetrahydrofolate-homocysteine methyltransferase reductase",
                "omim_gene": [
                    "602568"
                ],
                "alias_name": null,
                "gene_symbol": "MTRR",
                "hgnc_symbol": "MTRR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:7851299-7906138",
                            "ensembl_id": "ENSG00000124275"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:7851186-7906025",
                            "ensembl_id": "ENSG00000124275"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-04-20"
            },
            "entity_type": "gene",
            "entity_name": "MTRR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12555939",
                "15714522"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ABL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7467",
                "gene_name": "microsomal triglyceride transfer protein",
                "omim_gene": [
                    "157147"
                ],
                "alias_name": null,
                "gene_symbol": "MTTP",
                "hgnc_symbol": "MTTP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:100484918-100545156",
                            "ensembl_id": "ENSG00000138823"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:99563761-99623999",
                            "ensembl_id": "ENSG00000138823"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-11-04"
            },
            "entity_type": "gene",
            "entity_name": "MTTP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "17275380",
                "34078172",
                "34052173",
                "33258201"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Abetalipoproteinaemia, MIM# 200100"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CD227",
                    "PEM",
                    "ADMCKD",
                    "ADMCKD1",
                    "MCKD",
                    "MCD"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7508",
                "gene_name": "mucin 1, cell surface associated",
                "omim_gene": [
                    "158340"
                ],
                "alias_name": null,
                "gene_symbol": "MUC1",
                "hgnc_symbol": "MUC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:155158300-155162707",
                            "ensembl_id": "ENSG00000185499"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:155185824-155192916",
                            "ensembl_id": "ENSG00000185499"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "MUC1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29186029",
                "29156055",
                "29520014"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Medullary cystic kidney disease 1 (MIM#174000)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MG1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7516",
                "gene_name": "mucin 5B, oligomeric mucus/gel-forming",
                "omim_gene": [
                    "600770"
                ],
                "alias_name": null,
                "gene_symbol": "MUC5B",
                "hgnc_symbol": "MUC5B",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:1244296-1283406",
                            "ensembl_id": "ENSG00000117983"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:1223066-1262172",
                            "ensembl_id": "ENSG00000117983"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-12-03"
            },
            "entity_type": "gene",
            "entity_name": "MUC5B",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21506741",
                "21506748"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "{Pulmonary fibrosis, idiopathic, susceptibility to}, MIM# 178500"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [
                "5'UTR"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ27047",
                    "MG2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7518",
                "gene_name": "mucin 7, secreted",
                "omim_gene": [
                    "158375"
                ],
                "alias_name": null,
                "gene_symbol": "MUC7",
                "hgnc_symbol": "MUC7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:71296209-71348714",
                            "ensembl_id": "ENSG00000171195"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:70430492-70482997",
                            "ensembl_id": "ENSG00000171195"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-06-04"
            },
            "entity_type": "gene",
            "entity_name": "MUC7",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "{Asthma, protection against} MIM#600807"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7525",
                "gene_name": "muscle associated receptor tyrosine kinase",
                "omim_gene": [
                    "601296"
                ],
                "alias_name": null,
                "gene_symbol": "MUSK",
                "hgnc_symbol": "MUSK",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:113431051-113563859",
                            "ensembl_id": "ENSG00000030304"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:110668771-110801620",
                            "ensembl_id": "ENSG00000030304"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-04-10"
            },
            "entity_type": "gene",
            "entity_name": "MUSK",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25537362",
                "25612909",
                "8653786",
                "31750350",
                "15496425",
                "19949040",
                "20371544",
                "32253145"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Fetal akinesia deformation sequence 1, MIM# 208150",
                "MONDO:0100101",
                "Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, MIM# 616325",
                "MONDO:0014587"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7526",
                "gene_name": "methylmalonyl-CoA mutase",
                "omim_gene": [
                    "609058"
                ],
                "alias_name": null,
                "gene_symbol": "MUT",
                "hgnc_symbol": "MUT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:49398073-49430904",
                            "ensembl_id": "ENSG00000146085"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:49430360-49463191",
                            "ensembl_id": "ENSG00000146085"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "MUT",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "1977311",
                "11528502",
                "12948746"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Methylmalonic aciduria, mut(0) type, MIM# 251000"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name",
                "treatable"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "LRBP",
                    "MK"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7530",
                "gene_name": "mevalonate kinase",
                "omim_gene": [
                    "251170"
                ],
                "alias_name": [
                    "LH receptor mRNA-binding protein",
                    "mevalonic aciduria"
                ],
                "gene_symbol": "MVK",
                "hgnc_symbol": "MVK",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:110011060-110035067",
                            "ensembl_id": "ENSG00000110921"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:109573255-109598117",
                            "ensembl_id": "ENSG00000110921"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-10-06"
            },
            "entity_type": "gene",
            "entity_name": "MVK",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12563048",
                "10401001",
                "28095071"
            ],
            "evidence": [
                "Expert Review Green",
                "Royal Melbourne Hospital",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mevalonic aciduria MIM#610377",
                "Porokeratosis 3, multiple types, MIM# 175900"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MXD2",
                    "MAD2",
                    "MXI",
                    "bHLHc11"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7534",
                "gene_name": "MAX interactor 1, dimerization protein",
                "omim_gene": [
                    "600020"
                ],
                "alias_name": null,
                "gene_symbol": "MXI1",
                "hgnc_symbol": "MXI1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:111967363-112047123",
                            "ensembl_id": "ENSG00000119950"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:110207605-110287365",
                            "ensembl_id": "ENSG00000119950"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-02-16"
            },
            "entity_type": "gene",
            "entity_name": "MXI1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7549",
                "gene_name": "myosin binding protein C, slow type",
                "omim_gene": [
                    "160794"
                ],
                "alias_name": null,
                "gene_symbol": "MYBPC1",
                "hgnc_symbol": "MYBPC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:101962131-102079796",
                            "ensembl_id": "ENSG00000196091"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:101568353-101686018",
                            "ensembl_id": "ENSG00000196091"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-12-15"
            },
            "entity_type": "gene",
            "entity_name": "MYBPC1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20045868",
                "22610851",
                "23873045",
                "26661508",
                "31264822",
                "31025394"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Arthrogryposis, distal, type 1B 614335",
                "Lethal congenital contracture syndrome 4, MIM# 614915",
                "Myopathy, congenital, with tremor MIM#618524"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        }
    ]
}